Kristine Peterson

Kristine Peterson is currently Independent Director at Enanta Pharmaceuticals, Inc. since 2017, Director at Greater Philadelphia Life Sciences Congress, Director at AFYX Therapeutics AS, Independent Non-Executive Director at Immunocore Holdings Plc since 2017, Non-Executive Director at Immunocore Ltd., and Lead Independent Director at Arrivent BioPharma, Inc. starting in 2025.
Former roles include Chief Executive Officer at Valeritas Holdings, Inc. from 2009 to 2016, Chief Executive Officer & Director at Valeritas, Inc. from 2009 to 2016, Group Chairman-Biotech Group at Johnson & Johnson from 2006 to 2009, Independent Director at ImmunoGen, Inc. from 2012 to 2024, Independent Non-Executive Director at Amarin Corp.
Plc from 2010 to 2023, Director at Biotechnology Innovation Organization, Independent Non-Executive Director at EyePoint, Inc. from 2017 to 2020, Independent Director at Paratek Pharmaceuticals, Inc. from 2016 to 2023, Principal at Bristol Myers Squibb Co., President & Senior VP-Commercial Operations at Biovail Corp.
from 2003 to 2004, and President at Biovail Pharmaceuticals LLC from 2003 to 2004.
Education includes undergraduate and MBA degrees from the University of Illinois At Urbana–Champaign, conferred in 1981 and 1983 respectively.